News Release

FOR IMMEDIATE RELEASE
November 10, 2026

Experience Matters: Piedmont Neurology Offers New Alzheimer’s Treatment Options in Greenwood

Independent practice builds on decades of community service and a legacy of advancing local neurological care

GREENWOOD, S.C. — The physicians who helped bring modern stroke treatment to Greenwood are continuing their commitment to advancing local neurological care by offering new treatments for eligible patients with early Alzheimer’s disease.

At Piedmont Neurology, Dr. Wayne B. Sida and Dr. Bret J. Warner bring more than 60 years of combined clinical experience to an independent, locally rooted practice. Both are board-certified neurologists serving Greenwood and surrounding communities.

Their guiding principle is simple: experience matters.

“Our commitment has always been to bring meaningful advances in neurological care to the community we serve,” said Dr. Sida. “That commitment included helping introduce clot-busting treatment for stroke patients in 1996 and building Greenwood’s first award-winning primary stroke center. Today, it includes helping people with early Alzheimer’s disease understand whether newer treatments may be appropriate for them.”

Understanding Alzheimer’s disease and the newer treatments

Dementia refers to a decline in memory, thinking, and reasoning severe enough to interfere with everyday life. Alzheimer’s disease is the most common cause of dementia among older adults. Although the risk increases with age, dementia is not a normal part of aging.

Newer Alzheimer’s treatments target amyloid, a protein that accumulates in abnormal clumps, or plaques, in the brain. Two FDA-approved medications—lecanemab, marketed as Leqembi, and donanemab, marketed as Kisunla—help remove amyloid and can slow the progression of memory, thinking, and functional difficulties in appropriately selected patients with early Alzheimer’s disease. They do not cure the disease or restore abilities already lost.

These treatments are intended for certain individuals with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia, with testing that confirms amyloid buildup. They are not intended for every person experiencing forgetfulness or for patients with moderate or advanced Alzheimer’s dementia.

“New treatment options offer hope, but they also require thoughtful decisions,” said Dr. Warner. “We want patients and families to understand the potential benefit, the risks, and the monitoring involved—not simply hear that a new medication is available.”

Treatment requires careful evaluation and ongoing monitoring, including MRI scans. Important risks include brain swelling and bleeding, known as amyloid-related imaging abnormalities, or ARIA. These changes may cause no symptoms but can sometimes be serious or life-threatening.

A longstanding commitment to Greenwood

Drs. Sida and Warner’s work with newer Alzheimer’s therapies continues a history of introducing advances in neurological care to the community.

Their broad training at the Medical College of Georgia helped shape a practice that treats a wide range of neurological conditions. Piedmont Neurology’s expertise includes multiple sclerosis, Parkinson’s disease, migraine disorders, neuropathy, muscle disorders, epilepsy, and spinal disorders. The physicians also have extensive experience administering Botox for appropriate neurological indications.

“Patients do not always come to us with a single, clearly defined problem,” said Dr. Sida. “Our broad experience helps us consider the whole neurological picture. We combine that perspective with careful listening and an understanding of what matters most to each patient.”

Independent care, informed choices

Piedmont Neurology remains an independent private practice, preserving a locally rooted choice for neurological care. Its services include in-office MRI, and its physicians emphasize individualized evaluation, clear explanations of treatment options, and attention to affordability.

“For us, independence means preserving a practice built around personal relationships and thoughtful medical decisions,” said Dr. Warner. “We are proud of our history in Greenwood, but our focus is on the people we care for today. We want them to feel heard, understand their choices, and have confidence in their plan of care—including a clear understanding of the costs involved.”

Patients and families concerned about persistent changes in memory or thinking are encouraged to seek an evaluation. Those interested in learning more about Alzheimer’s treatment options at Piedmont Neurology can contact (864) 227-5240 or visit www.piedmontneurologysc.com.

About Piedmont Neurology

Piedmont Neurology is an independent private neurology practice serving Greenwood, South Carolina, and surrounding communities. Board-certified neurologists Dr. Wayne B. Sida and Dr. Bret J. Warner bring more than 60 years of combined clinical experience to the evaluation and treatment of neurological disorders. The practice offers broad neurological care and in-office MRI services.